Unravelling the role of dipeptidyl peptidases-8/9 (DPP-8/9) in inflammatory osteoporosis: a comprehensive study investigating chrysin as a potential anti-osteoporotic agent
Article in Journal of Pharmacy and Pharmacology (September 2024)
The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.
Trifolirhizin reduces osteoclast formation and prevents inflammatory osteolysis by inhibiting RANKL‐induced activation of NF‐κB and MAPK signaling pathways and ROS
Article in Phytotherapy Research (August 2024)
Artemisinic acid attenuates osteoclast formation and titanium particle-induced osteolysis via inhibition of RANKL-induced ROS accumulation and MAPK and NF-κB signaling pathways
Article in Frontiers in Pharmacology (May 2024)